Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers

Neuroendocrine prostate cancers are very difficult to treat and often arise after androgen-deprivation therapy. Here the authors show that ADT activates CREB that acts by increasing EZH2 activity to promote neuroendocrine differentiation in prostate cancer, providing alternative avenues for therapy.

Guardado en:
Detalles Bibliográficos
Autores principales: Yan Zhang, Dayong Zheng, Ting Zhou, Haiping Song, Mohit Hulsurkar, Ning Su, Ying Liu, Zheng Wang, Long Shao, Michael Ittmann, Martin Gleave, Huanxing Han, Feng Xu, Wangjun Liao, Hongbo Wang, Wenliang Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/25a7d86d01c14730b94ebc63e65d2641
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25a7d86d01c14730b94ebc63e65d2641
record_format dspace
spelling oai:doaj.org-article:25a7d86d01c14730b94ebc63e65d26412021-12-02T16:49:18ZAndrogen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers10.1038/s41467-018-06177-22041-1723https://doaj.org/article/25a7d86d01c14730b94ebc63e65d26412018-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-06177-2https://doaj.org/toc/2041-1723Neuroendocrine prostate cancers are very difficult to treat and often arise after androgen-deprivation therapy. Here the authors show that ADT activates CREB that acts by increasing EZH2 activity to promote neuroendocrine differentiation in prostate cancer, providing alternative avenues for therapy.Yan ZhangDayong ZhengTing ZhouHaiping SongMohit HulsurkarNing SuYing LiuZheng WangLong ShaoMichael IttmannMartin GleaveHuanxing HanFeng XuWangjun LiaoHongbo WangWenliang LiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-17 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yan Zhang
Dayong Zheng
Ting Zhou
Haiping Song
Mohit Hulsurkar
Ning Su
Ying Liu
Zheng Wang
Long Shao
Michael Ittmann
Martin Gleave
Huanxing Han
Feng Xu
Wangjun Liao
Hongbo Wang
Wenliang Li
Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
description Neuroendocrine prostate cancers are very difficult to treat and often arise after androgen-deprivation therapy. Here the authors show that ADT activates CREB that acts by increasing EZH2 activity to promote neuroendocrine differentiation in prostate cancer, providing alternative avenues for therapy.
format article
author Yan Zhang
Dayong Zheng
Ting Zhou
Haiping Song
Mohit Hulsurkar
Ning Su
Ying Liu
Zheng Wang
Long Shao
Michael Ittmann
Martin Gleave
Huanxing Han
Feng Xu
Wangjun Liao
Hongbo Wang
Wenliang Li
author_facet Yan Zhang
Dayong Zheng
Ting Zhou
Haiping Song
Mohit Hulsurkar
Ning Su
Ying Liu
Zheng Wang
Long Shao
Michael Ittmann
Martin Gleave
Huanxing Han
Feng Xu
Wangjun Liao
Hongbo Wang
Wenliang Li
author_sort Yan Zhang
title Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
title_short Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
title_full Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
title_fullStr Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
title_full_unstemmed Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
title_sort androgen deprivation promotes neuroendocrine differentiation and angiogenesis through creb-ezh2-tsp1 pathway in prostate cancers
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/25a7d86d01c14730b94ebc63e65d2641
work_keys_str_mv AT yanzhang androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT dayongzheng androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT tingzhou androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT haipingsong androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT mohithulsurkar androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT ningsu androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT yingliu androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT zhengwang androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT longshao androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT michaelittmann androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT martingleave androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT huanxinghan androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT fengxu androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT wangjunliao androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT hongbowang androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
AT wenliangli androgendeprivationpromotesneuroendocrinedifferentiationandangiogenesisthroughcrebezh2tsp1pathwayinprostatecancers
_version_ 1718383323248590848